Rani Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RANI and other ETFs, options, and stocks.

About RANI

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA. 

CEO
Talat Imran
CEOTalat Imran
Employees
105
Employees105
Headquarters
San Jose, California
HeadquartersSan Jose, California
Founded
2012
Founded2012
Employees
105
Employees105

RANI Key Statistics

Market cap
192.00M
Market cap192.00M
Price-Earnings ratio
-1.99
Price-Earnings ratio-1.99
Dividend yield
Dividend yield
Average volume
2.79M
Average volume2.79M
High today
$1.60
High today$1.60
Low today
$1.45
Low today$1.45
Open price
$1.47
Open price$1.47
Volume
3.60M
Volume3.60M
52 Week high
$3.87
52 Week high$3.87
52 Week low
$0.387
52 Week low$0.387

Stock Snapshot

As of today, Rani Therapeutics(RANI) shares are valued at $1.57. The company's market cap stands at 192M, with a P/E ratio of -1.99.

As of 2025-12-05, Rani Therapeutics(RANI) stock has fluctuated between $1.45 and $1.60. The current price stands at $1.57, placing the stock +7.9% above today's low and -1.6% off the high.

Rani Therapeutics(RANI) shares are trading with a volume of 3.6M, against a daily average of 2.79M.

In the last year, Rani Therapeutics(RANI) shares hit a 52-week high of $3.87 and a 52-week low of $0.39.

In the last year, Rani Therapeutics(RANI) shares hit a 52-week high of $3.87 and a 52-week low of $0.39.

People also own

Based on the portfolios of people who own RANI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.